{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:39Z","timestamp":1793424759646,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key R&D Program of Zhejiang","award":["2023C03032"],"award-info":[{"award-number":["2023C03032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10067-026-08391-6","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:07:48Z","timestamp":1790878068000},"page":"6895-6906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-\u03b3 as a predictive biomarker for macrophage activation syndrome in systemic JIA: a chinese multicenter study"],"prefix":"10.1007","volume":"45","author":[{"given":"Xuefeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiguo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"8391_CR1","doi-asserted-by":"publisher","unstructured":"Ringold S, Angeles-Han S T, Beukelman T, et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.[J]. Arthritis & rheumatology (Hoboken, N.J.), 2019,71(6):846\u2013863.  https:\/\/doi.org\/10.1002\/art.40884.","DOI":"10.1002\/art.40884"},{"key":"8391_CR2","unstructured":"Petty R E, Southwood T R, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.[J]. The Journal of rheumatology, 2004,31(2):390\u2013392."},{"issue":"4","key":"8391_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","volume":"3","author":"A Consolaro","year":"2019","unstructured":"Consolaro A, Giancane G, Alongi A et al (2019) Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health 3(4):255\u2013263. https:\/\/doi.org\/10.1016\/S2352-4642(19)30027-6","journal-title":"Lancet Child Adolesc Health"},{"issue":"12","key":"8391_CR4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/ard-2024-225853","volume":"83","author":"A De Matteis","year":"2023","unstructured":"De Matteis A, Bindoli S, De Benedetti F et al (2023) Systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease. Ann Rheum Dis 83(12):1748\u20131761. https:\/\/doi.org\/10.1136\/ard-2024-225853","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8391_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12969-024-01028-5","volume":"22","author":"W Zhan","year":"2024","unstructured":"Zhan W, Yang J, Qiu L et al (2024) Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study. Pediatr Rheumatol Online J 22(1):96. https:\/\/doi.org\/10.1186\/s12969-024-01028-5","journal-title":"Pediatr Rheumatol Online J"},{"key":"8391_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OARRR.S151013","volume":"10","author":"B Lerkvaleekul","year":"2018","unstructured":"Lerkvaleekul B, Vilaiyuk S (2018) Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol Res Rev 10:117\u2013128. https:\/\/doi.org\/10.2147\/OARRR.S151013","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"10","key":"8391_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard-2023-224123","volume":"82","author":"B Shakoory","year":"2022","unstructured":"Shakoory B, Geerlinks A, Wilejto M et al (2022) The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis 82(10):1271\u20131285. https:\/\/doi.org\/10.1136\/ard-2023-224123","journal-title":"Ann Rheum Dis"},{"key":"8391_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.681875","volume":"8","author":"A Abdirakhmanova","year":"2021","unstructured":"Abdirakhmanova A, Sazonov V, Mukusheva Z et al (2021) Macrophage activation syndrome in pediatric systemic lupus erythematosus: a systematic review of the diagnostic aspects. Front Med 8:681875. https:\/\/doi.org\/10.3389\/fmed.2021.681875","journal-title":"Front Med"},{"issue":"5","key":"8391_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00296-019-04442-1","volume":"40","author":"D Poddighe","year":"2020","unstructured":"Poddighe D, Dauyey K (2020) Macrophage activation syndrome in juvenile dermatomyositis: a systematic review. Rheumatol Int 40(5):695\u2013702. https:\/\/doi.org\/10.1007\/s00296-019-04442-1","journal-title":"Rheumatol Int"},{"key":"8391_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-006524","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Tang Z, Liu H et al (2016) 2016 sJIA-MAS criteria and a step-up therapeutic approach in KD-MAS: insights from a combined cohort and literature review. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2025-006524","journal-title":"RMD Open"},{"key":"8391_CR11","doi-asserted-by":"publisher","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.[J]. Annals of the rheumatic diseases, 2016,75(3):481\u2013489. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208982.","DOI":"10.1136\/annrheumdis-2015-208982"},{"key":"8391_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE et al (2019) The immunology of macrophage activation syndrome. Front Immunol 10:119. https:\/\/doi.org\/10.3389\/fimmu.2019.00119","journal-title":"Front Immunol"},{"key":"8391_CR13","doi-asserted-by":"crossref","unstructured":"Lu M, Teng L, Xu Y, et al. Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.[Z]. 2023: 21, 115.","DOI":"10.1186\/s12969-023-00907-7"},{"issue":"2","key":"8391_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T et al (2019) Toward new classification criteria for juvenile idiopathic arthritis: first steps, Pediatric Rheumatology International Trials Organization international consensus. J Rheumatol 46(2):190\u2013197. https:\/\/doi.org\/10.3899\/jrheum.180168","journal-title":"J Rheumatol"},{"issue":"1","key":"8391_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61348-w","volume":"10","author":"X Xu","year":"2020","unstructured":"Xu X, Li H, Sheng Y et al (2020) Nomogram for prediction of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia. Sci Rep 10(1):4579. https:\/\/doi.org\/10.1038\/s41598-020-61348-w","journal-title":"Sci Rep"},{"issue":"1","key":"8391_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02599-9","volume":"24","author":"M Hu","year":"2023","unstructured":"Hu M, Shen C, Zheng F et al (2023) Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease. Respir Res 24(1):286. https:\/\/doi.org\/10.1186\/s12931-023-02599-9","journal-title":"Respir Res"},{"issue":"6","key":"8391_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11048","volume":"1","author":"EMA Eloseily","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB et al (2019) Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol 1(6):345\u2013349. https:\/\/doi.org\/10.1002\/acr2.11048","journal-title":"ACR Open Rheumatol"},{"key":"8391_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1469912","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan Y, Jin J et al (2024) Increased ferritin, serum lactate dehydrogenase, and aspartate aminotransferase levels predict macrophage activation syndrome complicating systemic lupus erythematosus: a retrospective study. Front Pediatr 12:1469912. https:\/\/doi.org\/10.3389\/fped.2024.1469912","journal-title":"Front Pediatr"},{"issue":"1","key":"8391_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10067-023-06828-w","volume":"43","author":"ED Batu","year":"2024","unstructured":"Batu ED, Sener S, Bal\u0131k Z et al (2024) Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis? Clin Rheumatol 43(1):415\u2013421. https:\/\/doi.org\/10.1007\/s10067-023-06828-w","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8391_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/keac247","volume":"62","author":"P Ruscitti","year":"2022","unstructured":"Ruscitti P, Ursini F, Berardicurti O et al (2022) Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still\u2019s disease. Rheumatology (Oxford, England) 62(1):321\u2013329. https:\/\/doi.org\/10.1093\/rheumatology\/keac247","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"8391_CR21","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J et al (2020) Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol 2(6):e358\u2013e367. https:\/\/doi.org\/10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"},{"key":"8391_CR22","doi-asserted-by":"publisher","unstructured":"Kaneko S, Shimizu M, Miyaoka F, et al. The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis.[J]. Clinical immunology (Orlando, Fla.), 2023,248:109270. https:\/\/doi.org\/10.1016\/j.clim.2023.109270.","DOI":"10.1016\/j.clim.2023.109270"},{"issue":"2","key":"8391_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","volume":"59","author":"SW Canna","year":"2012","unstructured":"Canna SW, Behrens EM (2012) Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin North Am 59(2):329\u2013344. https:\/\/doi.org\/10.1016\/j.pcl.2012.03.002","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"8391_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/acr2.11140","volume":"2","author":"TL Wampler Muskardin","year":"2020","unstructured":"Wampler Muskardin TL (2020) Intravenous Anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of coronavirus disease 2019. ACR Open Rheumatol 2(5):283\u2013285. https:\/\/doi.org\/10.1002\/acr2.11140","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"8391_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/acr2.11135","volume":"2","author":"LA Monteagudo","year":"2020","unstructured":"Monteagudo LA, Boothby A, Gertner E (2020) Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatol 2(5):276\u2013282. https:\/\/doi.org\/10.1002\/acr2.11135","journal-title":"ACR Open Rheumatol"},{"issue":"7","key":"8391_CR26","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1007\/s10238-023-00988-4","volume":"23","author":"T Hiyama","year":"2023","unstructured":"Hiyama T, Kurasawa K, Hasegawa A et al (2023) Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still\u2019s disease. Clin Exp Med 23(7):3407\u20133416. https:\/\/doi.org\/10.1007\/s10238-023-00988-4","journal-title":"Clin Exp Med"},{"issue":"1","key":"8391_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D et al (2017) Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis 76(1):166\u2013172. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8391_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/keae391","volume":"64","author":"F Baldo","year":"2025","unstructured":"Baldo F, Erkens RGA, Mizuta M et al (2025) Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology (Oxford) 64(1):32\u201344. https:\/\/doi.org\/10.1093\/rheumatology\/keae391","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8391_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-018-0303-4","volume":"17","author":"Y Li","year":"2019","unstructured":"Li Y, Zheng Q, Zou L et al (2019) Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-\u03b3 as biomarkers for early recognition. Pediatr Rheumatol Online J 17(1):1. https:\/\/doi.org\/10.1186\/s12969-018-0303-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"8391_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cyto.2016.07.018","volume":"86","author":"X Xu","year":"2016","unstructured":"Xu X, Li X, Liu J et al (2016) Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children. Cytokine 86:73\u201378. https:\/\/doi.org\/10.1016\/j.cyto.2016.07.018","journal-title":"Cytokine"},{"issue":"12","key":"8391_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3899\/jrheum.2024-0294","volume":"51","author":"F Haslak","year":"2024","unstructured":"Haslak F, Kilic H, Sahin S et al (2024) Children with type I interferonopathy: commonalities and diversities in a large patient cohort. J Rheumatol 51(12):1208\u20131217. https:\/\/doi.org\/10.3899\/jrheum.2024-0294","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08391-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:27Z","timestamp":1793423127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8391"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08391-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}